A phase 3 trial establishes 177Lu-dotatate plus long-acting octreotide as a new first-line treatment for patients with high-grade gastroenteropancreatic neuroendocrine tumors.

中文翻译：

---

神经内分泌肿瘤的放射配体治疗


一项 3 期试验确定 177Lu-dotatate 联合长效奥曲肽作为高级别胃肠胰腺神经内分泌肿瘤患者的新一线治疗方法。